Precigen (PGEN) EPS (Weighted Average and Diluted) (2012 - 2026)
Precigen (PGEN) reported EPS (Weighted Average and Diluted) of -$0.02 for Q1 2026, up 88.89% year-over-year from -$0.01 in Q1 2025, and down 100.0% quarter-over-quarter from -$0.01 in Q4 2025.
Precigen (PGEN) EPS (Weighted Average and Diluted) (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 13 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.02 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.02, up 88.89% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.18 (down 110.71% YoY), and the FY2025 annual result was -$1.37, down 191.49% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$0.02 in Q1 2026 per PGEN's latest filing, from -$0.01 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.01 in Q4 2025 and troughed at -$1.06 in Q3 2025.
- A 5-year average of -$0.15 and a median of -$0.09 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) plunged 1077.78% in 2025, then surged 88.89% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.11 in 2022, then declined by 18.18% to -$0.13 in 2023, then jumped by 53.85% to -$0.06 in 2024, then surged by 83.33% to -$0.01 in 2025, then tumbled by 100.0% to -$0.02 in 2026.
- Business Quant data shows PGEN's EPS (Weighted Average and Diluted) at -$0.02 in Q1 2026, -$0.01 in Q4 2025, and -$1.06 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.61 |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02 |
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -1.06 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | -0.06 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.23 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | -0.13 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.09 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | -0.22 |
| Sep 30, 2021 | -0.13 |
| Jun 30, 2021 | -0.10 |